HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...

Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets We used data from the 2017 National Survey ...

This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...

Please provide your email address to receive an email when new articles are posted on . A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic ...

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics (Babson), a transformative medical technology company, is improving the way the public receives diagnostic blood testing. According to the CDC, 70% ...